Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maryam Rahman

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
Neurosurgery|January 21, 2015
Insurance status influences the rates of reportable quality metrics in brain tumor patients: a nationwide inpatient sample studyKristopher G Hooten, Dan Neal, Rolando E Lovaton Espadin, et al.
Neurosurgery|December 8, 2010
The cancer stem cell hypothesis: failures and pitfallsMaryam Rahman, Loic Deleyrolle, Vinata Vedam-Mai, et al.
World Neurosurgery|October 26, 2016
Prophylactic Antiepileptic Drug Use in Patients with Brain Tumors Undergoing CraniotomyDennis T Lockney, Sasha Vaziri, Frank Walch, et al.
Neurosurgery|March 20, 2015
Establishing Standard Performance Measures in Adult Traumatic Brain Injury PatientsBrian M Corliss, Kristopher G Hooten, Sarah Shireen Gul, et al.
World Neurosurgery|October 7, 2022
Histologic Findings at the Time of Repeat Resection Predicts Survival in Patients with GlioblastomaKaitlyn Melnick, Patricia Miller, Ethan Carmichael, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 18, 2010
Atypical Rasmussen's encephalitis treated with temporal lobectomyMuhammad M Abd-El-Barr, Brenda Wu, Maryam Rahman, et al.
World Neurosurgery|December 22, 2019
Comparing Standard Performance and Outcome Measures in Hospitalized Pituitary Tumor Patients with Secretory versus Nonsecretory TumorsAlexander L Vlasak, David H Shin, Paul S Kubilis, et al.
Med (New York, N.Y.)|June 4, 2025
Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: A phase 2 studyDongjiang Chen, Son B Le, Ashley P Ghiaseddin, et al.
World Neurosurgery|February 11, 2014
When gross total resection of a glioblastoma is possible, how much resection should be achieved?Kaisorn L Chaichana, Eibar Ernesto Cabrera-Aldana, Ignacio Jusue-Torres, et al.
Stroke|April 10, 2010
Size ratio correlates with intracranial aneurysm rupture status: a prospective studyMaryam Rahman, Janel Smietana, Erik Hauck, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
Neurosurgery|January 21, 2015
Insurance status influences the rates of reportable quality metrics in brain tumor patients: a nationwide inpatient sample studyKristopher G Hooten, Dan Neal, Rolando E Lovaton Espadin, et al.
Neurosurgery|December 8, 2010
The cancer stem cell hypothesis: failures and pitfallsMaryam Rahman, Loic Deleyrolle, Vinata Vedam-Mai, et al.
World Neurosurgery|October 26, 2016
Prophylactic Antiepileptic Drug Use in Patients with Brain Tumors Undergoing CraniotomyDennis T Lockney, Sasha Vaziri, Frank Walch, et al.
Neurosurgery|March 20, 2015
Establishing Standard Performance Measures in Adult Traumatic Brain Injury PatientsBrian M Corliss, Kristopher G Hooten, Sarah Shireen Gul, et al.
World Neurosurgery|October 7, 2022
Histologic Findings at the Time of Repeat Resection Predicts Survival in Patients with GlioblastomaKaitlyn Melnick, Patricia Miller, Ethan Carmichael, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 18, 2010
Atypical Rasmussen's encephalitis treated with temporal lobectomyMuhammad M Abd-El-Barr, Brenda Wu, Maryam Rahman, et al.
World Neurosurgery|December 22, 2019
Comparing Standard Performance and Outcome Measures in Hospitalized Pituitary Tumor Patients with Secretory versus Nonsecretory TumorsAlexander L Vlasak, David H Shin, Paul S Kubilis, et al.
Med (New York, N.Y.)|June 4, 2025
Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: A phase 2 studyDongjiang Chen, Son B Le, Ashley P Ghiaseddin, et al.
World Neurosurgery|February 11, 2014
When gross total resection of a glioblastoma is possible, how much resection should be achieved?Kaisorn L Chaichana, Eibar Ernesto Cabrera-Aldana, Ignacio Jusue-Torres, et al.
Stroke|April 10, 2010
Size ratio correlates with intracranial aneurysm rupture status: a prospective studyMaryam Rahman, Janel Smietana, Erik Hauck, et al.
Pageof 13